Shaanxi Kanghui Pharmaceutical Co., Ltd.

Shanghai Stock Exchange 603139.SS

Shaanxi Kanghui Pharmaceutical Co., Ltd. Total Assets for the year ending December 31, 2023: USD 288.99 M

Shaanxi Kanghui Pharmaceutical Co., Ltd. Total Assets is USD 288.99 M for the year ending December 31, 2023, a 9.47% change year over year. Total assets are the total value of all assets owned by a company, representing its resources.

Shaanxi Kanghui Pharmaceutical Co., Ltd. Total Assets for the year ending December 31, 2022 was USD 263.98 M, a -9.83% change year over year.
Shaanxi Kanghui Pharmaceutical Co., Ltd. Total Assets for the year ending December 31, 2021 was USD 292.76 M, a 45.74% change year over year.
Shaanxi Kanghui Pharmaceutical Co., Ltd. Total Assets for the year ending December 31, 2020 was USD 200.88 M, a 23.72% change year over year.
Shaanxi Kanghui Pharmaceutical Co., Ltd. Total Assets for the year ending December 31, 2019 was USD 162.37 M, a 0.58% change year over year.

Key data

Date	Total Assets	Current Liabilities	Total Non-Current Liabilities	Shareholders' Equity

Shanghai Stock Exchange: 603139.SS

Shaanxi Kanghui Pharmaceutical Co., Ltd.

CEO	Mr. Yanling Wang
IPO Date	April 21, 2017
Location	China
Headquarters	High-tech Industrial Development Zone
Employees	952
Sector	Health Care
Industries Pharmaceuticals

Description

Shaanxi Kanghui Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in China. It offers gynecological, orthopedic, dermatology, diabetes, respiratory system, urinary system, cardiovascular and cerebrovascular, gastrointestinal, hepatobiliary, and other drugs in the form of tablets, capsules, granules, mixtures, teas, plasters, ointments, liniments, lotions, and tinctures. The company is based in Xianyang, China.

Key trends

Past 5 years